Sun Pharma Q2 net plunges 59% at Rs 912 cr
Analysts on average had expected a profit of Rs 827 crore, according to Thomson Reuters data
)
A logo of Sun Pharmaceutical Industries Ltd is pictured at its research and development centre in Mumbai (Photo: Reuters)
India's largest drugmaker, Sun Pharmaceutical Industries Ltd, posted a 59 per cent plunge in second-quarter profit on Tuesday, but beat estimates.
Profit came in at Rs 912 crore ($139.48 million) in the quarter ended Sept. 30, compared with Rs 2,235 crore a year ago, the company said.
Analysts on average had expected a profit of Rs 827 crore, according to Thomson Reuters data.
More From This Section
Topics : Sun Pharma
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2017 | 4:58 PM IST
